Results 251 to 260 of about 18,983,868 (378)
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Epidemiology of cancer-related pain in Africa: A systematic review and meta-analysis of studies from 2001 to 2024. [PDF]
Tadesse MA +15 more
europepmc +1 more source
Modelling Microstructural Evolution in Materials Science
Nana Ofori-Opoku
openalex +1 more source
Overview of molecular signatures of senescence and associated resources: pros and cons
Cells can enter a stress response state termed cellular senescence that is involved in various diseases and aging. Detecting these cells is challenging due to the lack of universal biomarkers. This review presents the current state of senescence identification, from biomarkers to molecular signatures, compares tools and approaches, and highlights ...
Orestis A. Ntintas +6 more
wiley +1 more source
Special Issue "Characteristics of Dental Ceramics". [PDF]
Amaral M, Baroudi K.
europepmc +1 more source
MATERIALS SCIENCE AND ENERGY FRACTAL NATURE NEW FRONTIERS
Vojislav V. Mitić +2 more
openalex +2 more sources
Targeting TNBC: core–shell polycationic polyurea dendrimers with inherent anticancer activity
Core–shell polycationic PURE dendrimers were tested in TNBC‐derived tumor models. Both formulations selectively targeted TNBC and effectively reduced tumor volume. PUREG4‐OEI48 suppressed tumor growth without detectable toxicity, whereas PUREG4‐OCEI24, despite showing efficacy, induced hepatic toxicity.
Adriana Cruz +9 more
wiley +1 more source
Unexpected Findings on Histology: Plant Seeds Inducing and Mimicking Gastrointestinal Diseases. [PDF]
Hegedűs F, Lantos T, Sejben A.
europepmc +1 more source

